Omniab, INC 10-Q quarterly reports
Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.
NASDAQ
OABI
Omniab, INCOmniAb, Inc. announced its second quarter 2026 financial results, showcasing a substantial increase in total revenue driven by license and milestone payments, while continuing to report net losses and a decrease in cash reserves.
NASDAQ
OABI
Omniab, INCOmniAb, Inc. announced its first quarter 2026 financial results, showcasing a significant 247% increase in total revenue driven by a substantial rise in license and milestone revenue.
NASDAQ
OABI
Omniab, INCOmniAb reported a significant decline in Q3 2025 revenue and an increased net loss, despite a recent $30 million private placement.
NASDAQ
OABI
Omniab, INCOmniAb, Inc. reported a significant net loss for Q2 2025, driven by substantial declines in license, milestone, service, and royalty revenues, despite reduced operating expenses.
NASDAQ
OABI
Omniab, INCOmniAb, Inc. reports its financial results for the first quarter ended March 31, 2025, showing a slight revenue increase and a reduced net loss compared to the same period in 2024.
NASDAQ
OABI
Omniab, INCOmniAb's third quarter 2024 results show a decrease in revenue compared to the same period last year, primarily due to lower milestone and service revenue.
NASDAQ
OABI
Omniab, INCOmniAb's second quarter 2024 results show a decrease in revenue primarily due to the timing of milestone recognition, while service revenue increased.
NASDAQ
OABI
Omniab, INCOmniAb's first quarter 2024 revenue decreased significantly compared to the same period last year, primarily due to the timing of milestone payments.